Halozyme Therapeutics, Inc. - Common Stock (HALO)
$57.99
0.51 (0.87%)
HALO Stock Quote Delayed 30 Minutes
HALO Stock Earnings: Halozyme Therapeutics Beats EPS, Beats Revenue for Q2 2024
HALO stock results show that Halozyme Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
8.25B
PE Ratio
16.91
EPS
3.43
Volume (Avg. Vol.)
1.24M
Day's Range
$57.50 - $58.98
52-Week Range
$37.73 - $65.53
Dividend & Yield
N/A (N/A)
HALO Stock Predictions, Articles, and Halozyme Therapeutics, Inc. - Common Stock News
3 Highly Rated Biotech Stocks for Your July Buy List
Discover three top-rated biotech stocks that are pushing forward the pharma and biotech revolution on Wall Street.
3 Breakout Biotech Stocks on Track to Double by 2032
The tech sector has been at the forefront of the market rally in 2024. Consider these breakout biotech stocks as a great way to diversify.
The 3 Best Healthcare Stocks to Buy in June 2024
Aging populations and changing lifestyles mean healthcare is a secular story in which these best healthcare stocks to buy will capitalize.
HALO Stock Earnings: Halozyme Therapeutics Beats EPS, Misses Revenue for Q1 2024
HALO stock results show that Halozyme Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Millionaire Secrets: 3 Stocks to Turn $1,000 Into a Fortune
Are you looking to invest in the stock market and become a millionaire? Here are three stocks to buy to turn $1,000 into a fortune.
Why Is Antares Pharma (ATRS) Stock Up Today?
Antares Pharma (ATRS) stock is rocketing higher on Wednesday after the company reached an acquisition agreement with Halozyme (HALO).
Why Foot Locker, Inc. (FL), Campbell Soup Company (CPB) and Halozyme Therapeutics, Inc. (HALO) Are 3 of Today’s Worst Stocks
Foot Locker (FL), Campbell Soup (CPB) and Halozyme Therapeutics (HALO) shareholders won't be starting the weekend in the best of moods.
3 Stocks to Watch on Thursday: Kohl’s Corporation (KSS), Halozyme Therapeutics, Inc. (HALO) and Sears Holdings Corp (SHLD)
Kohl's (KSS) is battered by an awful holiday performance, Sears (SHLD) sells off Craftsman and Halozyne (HALO) reports strong trial data.
